News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Fair Richard A.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 08/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2020 |
4
| Fair Richard A. (President and CEO) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC|
Txns:
| Granted 286,000 options to buy
@ $2.97, valued at
$849.4k
|
|
| 06/08/2020 |
4
| Fair Richard A. (Director) has filed a Form 4 on Clovis Oncology, Inc.|
Txns:
| Granted 40,138 options to buy
@ $6.48, valued at
$260.1k
|
|
| 03/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2020 |
4
| Fair Richard A. (President and CEO) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC|
Txns:
| Granted 1,257,000 options to buy
@ $1.36, valued at
$1.7M
|
|
| 09/11/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/23/2019 |
4
| Fair Richard A. (President and CEO) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC|
Txns:
| Bought 20,000 shares
@ $0.989, valued at
$19.8k
|
|
| 06/11/2019 |
4
| Fair Richard A. (President and CEO) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC|
Txns:
| Granted 300,000 options to buy
@ $1.87, valued at
$561k
|
|
| 06/07/2019 |
4
| Fair Richard A. (Director) has filed a Form 4 on Clovis Oncology, Inc.|
Txns:
| Granted 28,882 options to buy
@ $14.66, valued at
$423.4k
|
|
| 02/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/15/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/12/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/05/2018 |
4
| Fair Richard A. (President and CEO) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC|
Txns:
| Granted 225,000 options to buy
@ $7.72, valued at
$1.7M
|
|
| 01/04/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/01/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
|
|